ELVN
Price:
$27.9085
Market Cap:
$1.32B
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.[Read more]
Industry
Biotechnology
IPO Date
2020-03-12
Stock Exchange
NASDAQ
Ticker
ELVN
According to Enliven Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.22B. This represents a change of 88.18% compared to the average of 649.14M of the last 4 quarters.
The mean historical Enterprise Value of Enliven Therapeutics, Inc. over the last ten years is 173.14M. The current 1.22B Enterprise Value has changed 70.45% with respect to the historical average. Over the past ten years (40 quarters), ELVN's Enterprise Value was at its highest in in the June 2020 quarter at 1.85B. The Enterprise Value was at its lowest in in the December 2021 quarter at -81929234.00.
Average
173.14M
Median
250.20M
Minimum
-89110010.00
Maximum
392.10M
Discovering the peaks and valleys of Enliven Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0.97%
Maximum Annual Enterprise Value = 392.10M
Minimum Annual Increase = -1726.97%
Minimum Annual Enterprise Value = -89110010.00
Year | Enterprise Value | Change |
---|---|---|
2023 | 392.10M | -1726.97% |
2022 | -24099877.36 | -72.95% |
2021 | -89110010.00 | -150.41% |
2020 | 176.78M | -30.48% |
2019 | 254.27M | 0.97% |
2018 | 251.82M | 0.65% |
The current Enterprise Value of Enliven Therapeutics, Inc. (ELVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
92.96M
5-year avg
141.99M
10-year avg
173.14M
Enliven Therapeutics, Inc.’s Enterprise Value is greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than PMV Pharmaceuticals, Inc. (48.39M), greater than Cullinan Oncology, Inc. (813.60M), greater than Immuneering Corporation (-252222.00), greater than Aerovate Therapeutics, Inc. (48.28M), less than MoonLake Immunotherapeutics (2.62B), less than Structure Therapeutics Inc. (1.92B), greater than Compass Therapeutics, Inc. (210.95M), greater than Replimune Group, Inc. (750.98M), greater than Nuvectis Pharma, Inc. (100.52M), greater than Lyra Therapeutics, Inc. (21.96M), greater than Kronos Bio, Inc. (12.41M), greater than Gossamer Bio, Inc. (311.69M), greater than Eliem Therapeutics, Inc. (119.64M), greater than Inhibrx Biosciences, Inc. (-1613872.00), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), greater than Celcuity Inc. (640.20M),
Company | Enterprise Value | Market cap |
---|---|---|
138.26M | $181.50M | |
48.39M | $84.75M | |
813.60M | $925.89M | |
-252222.00 | $55.16M | |
48.28M | $78.66M | |
2.62B | $2.96B | |
1.92B | $2.30B | |
210.95M | $233.21M | |
750.98M | $826.69M | |
100.52M | $118.63M | |
21.96M | $17.12M | |
12.41M | $55.49M | |
311.69M | $199.69M | |
119.64M | $342.68M | |
-1613872.00 | $223.08M | |
-10189682.00 | $223.97M | |
640.20M | $574.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enliven Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enliven Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Enliven Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?
What is the 3-year average Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?
What is the 5-year average Enterprise Value for Enliven Therapeutics, Inc. (ELVN)?
How does the current Enterprise Value for Enliven Therapeutics, Inc. (ELVN) compare to its historical average?